Spatial organization

Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023

Retrieved on: 
Tuesday, October 31, 2023
Biomarker, Society for Immunotherapy of Cancer, Head, Organization, Entrepreneurship, Research, Poster, HNSCC, SITC, Tissue, Immunotherapy, Proteome, Annual general meeting, University, Tumor microenvironment, Society, Patient, Spatial organization, Translation, Cultured pearl, Fine chemical, Medical imaging, Communications satellite, Akoya, Stroma, Neoplasm

MARLBOROUGH, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced that it will be showcasing its latest Spatial Biology 2.0 solutions and ultrahigh-plex (100+ protein biomarkers) spatial phenotyping data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, being held in San Diego, California, November 1-5, 2023.

Key Points: 
  • MARLBOROUGH, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced that it will be showcasing its latest Spatial Biology 2.0 solutions and ultrahigh-plex (100+ protein biomarkers) spatial phenotyping data at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting, being held in San Diego, California, November 1-5, 2023.
  • At booth #719, Akoya Biosciences will highlight its new PhenoCycler®-Fusion 2.0 and PhenoImager® HT 2.0 platforms, which offer significant advancements in speed and scale for spatial biology research.
  • PhenoCycler-Fusion 2.0: Features multi-slide automation, enabling researchers to generate ultrahigh-plex spatial phenotyping data for larger and more complex samples at unprecedented speed.
  • “We’re excited to be at SITC where we will highlight these innovations and share an extensive array of new spatial phenotyping data.

Akoya Biosciences Announces Founding Members of First-of-its-Kind Imaging Innovators (I²) Network

Retrieved on: 
Tuesday, November 2, 2021
Massachusetts Institute of Technology, I2, Biology, Research, Lists of diseases, University, Map, Disease, Goal, Massachusetts, Immunology, Wellcome Sanger Institute, Security (finance), U.S. Securities and Exchange Commission, Harvard University, Beth Israel, Developmental biology, Terminology, Infection, RNA, Center, CODEX, Brain, Bachelor of Engineering, Software, Forward-looking statement, Virology, Neuroscience, CEO, Growth, Program, Solution, Health, Nasdaq, MIT, Spatial organization, Cerebral cortex, GLOBE, Doctor of Philosophy, HIV disease progression rates, Microscope, Medical imaging, Pharmaceutical industry

MARLBOROUGH, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company®, today announced the first members of the Akoya Imaging Innovators (I²) Network, a collaboration of pioneering scientists from world-class research organizations, with ambitions to advance the field of spatial biology.

Key Points: 
  • MARLBOROUGH, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences Inc., (Nasdaq: AKYA) The Spatial Biology Company, today announced the first members of the Akoya Imaging Innovators (I ) Network , a collaboration of pioneering scientists from world-class research organizations, with ambitions to advance the field of spatial biology.
  • Akoya established the program to encourage leaders in diverse fields of research to pursue disruptive applications within spatial phenotyping.
  • Akoya is excited to foster transformative research and applications for spatial phenotyping through the I2 Network," said Brian McKelligon, CEO at Akoya Biosciences.
  • Network members will also have first access to pre-release CODEX tools and may influence future product strategy.

NanoString Unveils Spatial Organ Atlas During the American Society of Human Genetics (ASHG) Conference

Retrieved on: 
Monday, October 18, 2021
Software, Research, Other Health, Oncology, Technology, Medical Devices, Genetics, Science, Nanotechnology, Biotechnology, Other Technology, Health, Other Science, Solution, Time, MicroRNA, Brain, Conference, Disease, Transcriptome, Nature Communications, Colon, Lymph, Data, Research, Kidney, SMI, Architecture, Tissue, Centre for Industry Education Collaboration, RNA, Health, Weill Cornell Medicine, Günther Pancke, NanoString Technologies, Alpha, Technology, Endothelium, Doctor of Philosophy, Department, Epithelium, Multimedia, Pancreas, Biology, Poster, Department of Medicine – University of Pamplona, NASDAQ, COVID-19, DSP, Mount Sinai, Cancer, Gene, Icahn School of Medicine at Mount Sinai, Biophysics, Protein, Micro-Imaging Dust Analysis System, Spatial organization, Physiology, WTA, Medical imaging, Microscope, Interior design

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    "The Spatial Organ Atlas maps the whole transcriptomes of the multi-cellular molecular machines that drive organ biology," said Joseph Beechem, Ph.D., chief scientific officer, NanoString.
  • The Spatial Organ Atlas can be explored on NanoString's website, http://www.nanostring.com/spatial-organ-atlas , through downloadable datasets, including images, sequencing data, and analysis results.
  • Dr. Beechem will provide details of the Spatial Organ Atlas initiative and highlight the latest technological advancements at NanoString.
  • NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.